vs

Side-by-side financial comparison of CuriosityStream Inc. (CURI) and Ispire Technology Inc. (ISPR). Click either name above to swap in a different company.

Ispire Technology Inc. is the larger business by last-quarter revenue ($20.3M vs $19.2M, roughly 1.1× CuriosityStream Inc.). CuriosityStream Inc. runs the higher net margin — -19.7% vs -32.5%, a 12.8% gap on every dollar of revenue. On growth, CuriosityStream Inc. posted the faster year-over-year revenue change (35.8% vs -51.5%). CuriosityStream Inc. produced more free cash flow last quarter ($3.9M vs $-4.0M). Over the past eight quarters, CuriosityStream Inc.'s revenue compounded faster (26.5% CAGR vs -17.8%).

Curiosity Stream Inc., formerly branded as CuriosityStream, is an American media company and over-the-top subscription video streaming service which offers documentary programming including films, series, and TV shows. The company offers a video on demand subscription service branded as "Curiosity Stream" and a linear broadcast television channel known as the Curiosity Channel through various services including FuboTV and The Roku Channel.

Ispire Technology Inc. is a global tech firm specializing in R&D, manufacturing and sales of advanced vaporization hardware and supporting consumables. It serves nicotine and legal cannabis consumer markets, operates two core segments of hardware and branded cannabis products, covers North America, Europe and Asia-Pacific, delivering compliant innovative vapor solutions for B2B partners and end users.

CURI vs ISPR — Head-to-Head

Bigger by revenue
ISPR
ISPR
1.1× larger
ISPR
$20.3M
$19.2M
CURI
Growing faster (revenue YoY)
CURI
CURI
+87.3% gap
CURI
35.8%
-51.5%
ISPR
Higher net margin
CURI
CURI
12.8% more per $
CURI
-19.7%
-32.5%
ISPR
More free cash flow
CURI
CURI
$8.0M more FCF
CURI
$3.9M
$-4.0M
ISPR
Faster 2-yr revenue CAGR
CURI
CURI
Annualised
CURI
26.5%
-17.8%
ISPR

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
CURI
CURI
ISPR
ISPR
Revenue
$19.2M
$20.3M
Net Profit
$-3.8M
$-6.6M
Gross Margin
17.1%
Operating Margin
-17.6%
-33.9%
Net Margin
-19.7%
-32.5%
Revenue YoY
35.8%
-51.5%
Net Profit YoY
-34.6%
17.4%
EPS (diluted)
$-0.07
$-0.12

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CURI
CURI
ISPR
ISPR
Q4 25
$19.2M
$20.3M
Q3 25
$18.4M
$30.4M
Q2 25
$19.0M
$20.1M
Q1 25
$15.1M
$26.2M
Q4 24
$14.1M
$41.8M
Q3 24
$12.6M
$39.3M
Q2 24
$12.4M
$37.3M
Q1 24
$12.0M
$30.0M
Net Profit
CURI
CURI
ISPR
ISPR
Q4 25
$-3.8M
$-6.6M
Q3 25
$-3.7M
$-3.3M
Q2 25
$784.0K
$-14.8M
Q1 25
$319.0K
$-10.9M
Q4 24
$-2.8M
$-8.0M
Q3 24
$-3.1M
$-5.6M
Q2 24
$-2.0M
$-3.5M
Q1 24
$-5.0M
$-5.9M
Gross Margin
CURI
CURI
ISPR
ISPR
Q4 25
17.1%
Q3 25
17.0%
Q2 25
12.3%
Q1 25
18.2%
Q4 24
18.5%
Q3 24
19.5%
Q2 24
28.3%
Q1 24
20.4%
Operating Margin
CURI
CURI
ISPR
ISPR
Q4 25
-17.6%
-33.9%
Q3 25
-24.5%
-8.9%
Q2 25
2.5%
-72.7%
Q1 25
0.5%
-40.4%
Q4 24
-27.4%
-17.6%
Q3 24
-25.8%
-13.4%
Q2 24
-20.6%
-9.2%
Q1 24
-30.4%
-18.8%
Net Margin
CURI
CURI
ISPR
ISPR
Q4 25
-19.7%
-32.5%
Q3 25
-20.4%
-10.7%
Q2 25
4.1%
-73.4%
Q1 25
2.1%
-41.5%
Q4 24
-19.9%
-19.1%
Q3 24
-24.3%
-14.2%
Q2 24
-16.4%
-9.4%
Q1 24
-42.0%
-19.7%
EPS (diluted)
CURI
CURI
ISPR
ISPR
Q4 25
$-0.07
$-0.12
Q3 25
$-0.06
$-0.06
Q2 25
$0.01
$-0.26
Q1 25
$0.01
$-0.19
Q4 24
$-0.05
$-0.14
Q3 24
$-0.06
$-0.10
Q2 24
$-0.04
$-0.07
Q1 24
$-0.09
$-0.11

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CURI
CURI
ISPR
ISPR
Cash + ST InvestmentsLiquidity on hand
$27.3M
$17.6M
Total DebtLower is stronger
Stockholders' EquityBook value
$41.5M
$-7.7M
Total Assets
$75.7M
$84.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CURI
CURI
ISPR
ISPR
Q4 25
$27.3M
$17.6M
Q3 25
$27.8M
$22.7M
Q2 25
$28.1M
$24.4M
Q1 25
$33.4M
$23.5M
Q4 24
$32.1M
$34.4M
Q3 24
$33.2M
$37.7M
Q2 24
$39.5M
$35.1M
Q1 24
$38.8M
$39.5M
Stockholders' Equity
CURI
CURI
ISPR
ISPR
Q4 25
$41.5M
$-7.7M
Q3 25
$47.2M
$-1.8M
Q2 25
$49.8M
$604.7K
Q1 25
$58.1M
$14.8M
Q4 24
$57.8M
$24.2M
Q3 24
$62.2M
$30.7M
Q2 24
$64.8M
$34.5M
Q1 24
$67.0M
$35.9M
Total Assets
CURI
CURI
ISPR
ISPR
Q4 25
$75.7M
$84.4M
Q3 25
$74.7M
$96.4M
Q2 25
$78.7M
$102.2M
Q1 25
$85.3M
$115.7M
Q4 24
$86.2M
$132.0M
Q3 24
$87.6M
$129.0M
Q2 24
$90.9M
$122.6M
Q1 24
$94.6M
$108.0M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CURI
CURI
ISPR
ISPR
Operating Cash FlowLast quarter
$4.0M
$-4.0M
Free Cash FlowOCF − Capex
$3.9M
$-4.0M
FCF MarginFCF / Revenue
20.5%
-19.9%
Capex IntensityCapex / Revenue
0.1%
0.3%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-14.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CURI
CURI
ISPR
ISPR
Q4 25
$4.0M
$-4.0M
Q3 25
$4.4M
$-1.2M
Q2 25
$2.8M
$4.7M
Q1 25
$1.9M
$-12.5M
Q4 24
$3.0M
$-3.2M
Q3 24
$2.3M
$3.6M
Q2 24
$2.2M
$-1.4M
Q1 24
$666.0K
$3.4M
Free Cash Flow
CURI
CURI
ISPR
ISPR
Q4 25
$3.9M
$-4.0M
Q3 25
$-1.2M
Q2 25
$3.7M
Q1 25
$1.8M
$-12.7M
Q4 24
$-3.2M
Q3 24
$3.3M
Q2 24
$-2.2M
Q1 24
$3.3M
FCF Margin
CURI
CURI
ISPR
ISPR
Q4 25
20.5%
-19.9%
Q3 25
-3.9%
Q2 25
18.6%
Q1 25
12.2%
-48.4%
Q4 24
-7.7%
Q3 24
8.5%
Q2 24
-5.9%
Q1 24
10.9%
Capex Intensity
CURI
CURI
ISPR
ISPR
Q4 25
0.1%
0.3%
Q3 25
0.0%
0.0%
Q2 25
0.0%
4.8%
Q1 25
0.5%
0.7%
Q4 24
0.0%
0.1%
Q3 24
0.0%
0.7%
Q2 24
0.0%
2.0%
Q1 24
0.0%
0.3%
Cash Conversion
CURI
CURI
ISPR
ISPR
Q4 25
Q3 25
Q2 25
3.56×
Q1 25
6.03×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons